C-RAD announces a significant milestone in the field of particle therapy with an order from the proton therapy market leader
After the
All nine centers will be equipped with Sentinel 4DCT at the planning CT (for 4DCT and DIBH) and Catalyst+ PT at the IBA Proteus®ONE treatment room for positioning, motion monitoring and respiratory gated particle treatments. Catalyst+ PT supports the entire proton therapy workflow, ensuring optimal treatment outcomes without exposing the patients to non-prescribed radiation doses.
Mattias Nilsing, Product Manager SGRT for Particle Therapy and CT Imaging at C-RAD, added: “Particle therapy stands at the forefront of precise cancer radiation therapy and we take immense pride in being partners with IBA, facilitating these cutting-edge treatments. C-RAD’s first proton project with IBA dates back to 2015. Since then, our collaboration has resulted in several successful installations at leading cancer centers worldwide, confirming the products’ technical excellence and a solid, long-lasting partnership.”
The deliveries are expected to start earliest in 2025 and will continue over several years.
Service contracts have not been included in this order but could be added at a later stage, along with the deliveries.
© Modular Finance, source